MEA Pharmaceuticals Packaging Market: Current Analysis and Forecast (2021-2028)
$3500 – $6860
Emphasis on Material Type (Plastics & Polymers, Paper and Paperboard, Glass, Aluminum Foil, Others); Product Type [Primary Pharmaceutical Packaging (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Others), Secondary Pharmaceutical Packaging (Prescription Containers, Pharmaceutical Packaging Accessories), Tertiary Pharmaceutical Packaging]; End-Users (Contract Packaging, Pharmaceutical Manufacturing, Retail Pharmacy, Institutional Pharmacy & Others) and Region & Country.
MEA Pharmaceuticals Packaging Market was valued at ~US$ 7 billion in 2020 and is expected to grow at a CAGR of ~8.2% over the forecast period (2021-2027). Pharmaceutical Packaging is mainly done using drug-compatible materials to provide protection, presentation, identification, information, compliance, convenience, integrity, and stability of the product. Pharmaceutical packaging is made by using a variety of materials such as plastics & polymers, paper and paperboard, glass, aluminum foil, and others. In the African region, the technologies are creating several opportunities to leapfrog in the Healthcare Sector, as revealed by the United Nations Industrial Development Organization.
The demand for the Pharmaceutical packaging market is booming in the Middle East and Africa (MEA) region owing to the opening of production facilities in the region, advanced manufacturing processes, sterilized tracking, and tracing of drugs, rising genetic drug market, emerging growth in the Drug Delivery market, increase in R&D initiatives, rise in population, increase in the prevalence of chronic diseases coupled with the aging population, and increase in demand for convenient and sterile packaging. Moreover, the increasing advancements in Drug Discovery and the rising demand for Over Counter (OTC) Drugs, also propel the market growth.
GDP Per Capita (Current US$) in the Middle East and Africa (MEA), 2019
Insights Presented in the Report
“Amongst Material Type, Plastics & polymers segment holds the major share.”
Based on Material Type, the market is bifurcated into Plastics & Polymers, Paper and Paperboard, Glass, and Aluminum Foil, and Others. The demand for the plastic & polymers segment is increasing owing to the increase in the use of PVC, polypropylene, polycarbonate, polyethylene terephthalate, and high-thickened polyethylene in the packaging for pharmaceutical purposes due to its lightweight, low cost, good barrier properties, and strength. Constantia Flexibles Group is boosting its position in the Sub-Saharan African market through its acquisition with the South African flexible packaging company Afripack, and in February 2021 Constantia Flexibles launched its first mono-material, Perpetua, which protects the product from oxygen, light, and water vapor.
Amongst Product Type, the Primary Pharmaceutical Packaging segment holds the major share”
Based on by product type, the market is bifurcated into primary pharmaceutical packaging, secondary pharmaceutical packaging, and tertiary pharmaceutical packaging. The primary pharmaceutical packaging is further bifurcated into plastic bottles, caps & closures, parenteral containers, blister packs, prefillable inhalers, and others. The secondary pharmaceutical packaging is further bifurcated into prescription containers and pharmaceutical packaging accessories
Amongst End-User, Pharmaceutical manufacturing holds the major share”
Based on end-user, the market is bifurcated into contract packaging, pharmaceutical manufacturing, retail pharmacy, institutional pharmacy, and others. Contract packaging is anticipated to show the highest growth in the market in the forecast period owing to the growing focus on outsourcing the packaging activities to save time as well as packaging costs. In April 2019, GlaxoSmithKline (GSK) announced its partnership with Neopharma to localize its Secondary Packaging stage (the last phase of the manufacturing process) before distribution and sale. This partnership reduced the manufacturing process time to only three months, offering UAE patients faster access to the widely prescribed medicines.
“Saudi Arabia signifies one of the largest markets of Middle East & Africa (MEA) Pharmaceutical Packaging Market.”
For a better understanding of the market dynamics of the MEA Pharmaceuticals Packaging Market, a detailed analysis was conducted for different countries across the region including Saudi Arabia, UAE, Turkey, Egypt, Qatar, South Africa, and the Rest of MEA. Saudi Arabia dominated the market and generated revenue of US$ 2.2 billion in 2020 owing to highly developed pharma infrastructures and government support for the manufacturing sector.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Middle East & Africa (MEA) Pharmaceutical Packaging Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|1.2||Objective of the Study|
|1.5||Currency Used in Report|
|1.6||Scope of the Middle East & Africa (MEA) Pharmaceutical Packaging Market|
|2.1||Research Methodology for the Middle East & Africa (MEA) Pharmaceutical Packaging Market|
|2.1.1||Main Objective of the Middle East & Africa (MEA) Pharmaceutical Packaging Market|
|3.1||Estimated number of new Cancer cases in Middle East and Northern Africa (MEA) in 2020|
|3.2||GDP Per Capita (Current US$) in Middle East and Africa (MEA), 2019|
|5.1.1||Rising Prevalence of new HIV infections|
|5.1.2||Promulgating Cross Border Trade Activities|
|5.1.3||Boost in the Export of Plastic and Rubber in the MEA region|
|5.2.1||Counterfeit medicine problem|
|5.3.1||The tremendous growth in biologics and cold chain|
|5.3.2||Rising Prevalence of infectious diseases|
|5.4.1||Automation in Pharmaceutical Packaging industries|
|5.4.2||Advancements in Healthcare 3D Printing Market|
|6||KEY FACTS ON MEA PHARMA INDUSTRY|
|7||PHARMACEUTICAL PACKAGING AMID COVID-19|
|10.1||Demand Side Analysis|
|10.2||Supply Side Analysis|
|10.2.1||Top Product Launches|
|10.2.2||Top Partnerships and Expansion|
|10.2.3||Top Merger and Acquisitions|
|11||VALUE CHAIN ANALYSIS|
|12.1||Plastics & Polymers|
|12.2||Paper and Paperboard|
|13.1||Primary Pharmaceutical Packaging|
|13.1.2||Caps & Closures|
|13.2||Secondary Pharmaceutical Packaging|
|13.2.2||Pharmaceutical Packaging Accessories|
|13.3||Tertiary Pharmaceutical Packaging|
|14.4||Institutional Pharmacy and Others|
|15.7||Rest of Middle East and Africa|
|16.1||MEA Pharmaceutical Packaging, Market Share, Based on Uses, 2020 (%)|
|16.2||MEA Pharmaceutical Packaging, Based on Preference of Purchase 2018-2019 (%)|
|17.1||CCL Industries Inc|
|17.6||West Pharmaceutical Services, Inc.|
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Middle East & Africa (MEA) Pharmaceutical Packaging Market were the three major steps undertaken to create and analyze the adoption of the Middle East & Africa (MEA) Pharmaceutical Packaging for the different applications across major sectors such as Contract Packaging, Pharmaceutical Manufacturing, Retail Pharmacy, Institutional Pharmacy, and Others. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Middle East & Africa (MEA) Pharmaceutical Packaging sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detailed secondary study was conducted to obtain the historical market size of the Middle East & Africa (MEA) Pharmaceutical Packaging through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Middle East & Africa (MEA) Pharmaceutical Packaging market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are Material Type, Product Type, and End-User. Further country-level analyses were conducted to evaluate the overall adoption of Middle East & Africa (MEA) Pharmaceutical Packaging in every region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Pharmaceutical Packaging. Further, we conducted factor analysis using dependent and independent variables such as advanced manufacturing processes, sterilized tracking, and tracing of drugs, rising genetic drug market, emerging growth in the drug delivery market, increase in R&D initiatives, rise in population, increase in the prevalence of chronic diseases coupled with the aging population, and increase in demand for convenient and sterile packaging. Moreover, the increasing advancements in drug discovery and the rising demand for Over Counter (OTC) Drugs, also propel the market growth. The growth is spurred by the Rigorous control regulations and administration demand. For instance, East Africa Community Medicines Regulatory Harmonization Program was launched in Arusha Tanzania to address key weaknesses faced by the seven National Medicine Regulatory Authorities (NMRAs) in the region in developing as well as implementing medicine registration procedures compatible with internationally accepted standards.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Middle East & Africa (MEA) Pharmaceutical Packaging Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach was applied to arrive at the market forecast of about 2028 for different segments and subsegments across the major markets. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (USD) and the adoption rate of Middle East & Africa (MEA) Pharmaceutical Packaging across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the Middle East & Africa (MEA) Pharmaceutical Packaging market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Middle East & Africa (MEA) pharmaceutical packaging market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of material type, product type, end-user, and region.
Main Objective of the Middle East & Africa (MEA) Pharmaceutical Packaging Market Study
The current & future market trends of Middle East & Africa (MEA) Pharmaceutical Packaging were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of Middle East & Africa (MEA) Pharmaceutical Packaging in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of material type, product type, end-user, and region
- Define and analysis of the regulatory framework for the Middle East & Africa (MEA) Pharmaceutical Packaging industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Middle East & Africa (MEA) Pharmaceutical Packaging market for the major region
- Major regions studied in the report include the Middle East and Africa (UAE, Saudi Arabia, Qatar, Turkey, Egypt, South Africa, and the Rest of Middle East and Africa)
- Company profiles of the Middle East & Africa (MEA) Pharmaceutical Packaging market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry